Lumosa Phase 1 Unit — Cypress, California

Lumosa Phase 1 Unit is a clinical research site located in Cypress, California, United States 90630.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Lumosa Phase 1 Unit has participated in 1 clinical trials.

Therapeutic areas: Acute Ischemic Stroke.

Sponsors: Lumosa Therapeutics Co., Ltd..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cypress

Browse all research sites in California · View every site in Cypress

• WCCT Global
• West Coast Clinical Trials
• Altasciences Clinical Los Angeles
• WCCT
• Research Site
• Altasciences Clinical LA, Inc.
• Altasciences
• GSK Investigational Site
• Novartis Investigative Site
• Atea Study Site
• Theravance Biopharma Investigational Site
• Altasciences - Los Angeles

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lumosa Phase 1 Unit?

Lumosa Phase 1 Unit has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lumosa Phase 1 Unit conducted?

Lumosa Phase 1 Unit has 1 clinical trials on record. Their work covers Acute Ischemic Stroke.

Is Lumosa Phase 1 Unit accredited by Crixeo Clinical Trials?

Lumosa Phase 1 Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lumosa Phase 1 Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.